Apheresis Data

Cancer patients who are treated by a kind of apheresis in which particular inhibitors are removed from their plasma, by chance or by design, find that their tumors shrink.  Pioneered by Dr. Rigdon Lentz, over the last 30 years, several hundred patients have been treated worldwide in various safe-harbor jurisdictions.  The cumulative experience of these stage III/IV solid tumor patients has been an almost universal response, with many patients seeing more than a 50% reduction in their tumor burden.  Hemotherapies, a liver dialysis company, accidentally removed inhibitors during their therapy for liver failure.  The net result was a dramatic reduction in the size of liver tumors. Aethlon, removing another class of inhibitor, has seen similar results. Biopheresis, GmBh in Germany has created the OncoSorb column and completed a CE Mark approval. Its first safety trial has concluded positively. An effectiveness trial is underway.

But the most powerful evidence is from one statistical outlier patient. Most notably, one patient with an aggressive breast cancer, opted for inhibitor removal as opposed to standard chemotherapy. Her immune system was intact, undamaged by either radiation or chemotherapy.  During therapy a powerful immune response was engendered and she was treated for three months until anemia complications halted her therapy.  Upon returning to the United States her orthodox physicians at a major academic medical center panicked seeing the large nodule in her breast and immediately performed surgery.  Much to the chagrin of the academics and the pathologist that had performed her original biopsy prior to inhibitor removal therapy, the 6 centimeter diameter ball of tissue that was removed was found to be solely scar tissue, with one or two cancer cells.  Those cancer cells, however, were tightly locked in the tissue and felt to be no threat.  She went on to have a multi-year remission when she had been given less than 6 months to live at time of diagnosis.

In our initial experiment, three dogs with cancer were treated by a simple variant of apheresis, for proof of principle.  All three dogs had a primary tumor and many metastasis that could be easily seen on an x-ray.  Within the first 3 weeks of treatment, all the metastasis, some of which were the size of golf-balls, vanished without a trace.  Over the next 9 weeks, the primary tumors continued to shrink.  In one dog, the primary, which at the beginning was 2 inches in diameter and easily visible in the dog’s throat was, by the end of the 12 weeks of treatment, the shape, size and thinness of a dime.

Unfortunately, because all of the rest of the data in the world is not ours, we are not allowed to release it here. Reveal’s Data is still being collected. When that is completed, we will release it here…